| 000 | 01799 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250511164011.0 | ||
| 264 | 0 | _c19760213 | |
| 008 | 197602s 0 0 eng d | ||
| 022 | _a0008-543X | ||
| 024 | 7 |
_a10.1002/1097-0142(197511)36:5<1560::aid-cncr2820360504>3.0.co;2-5 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCarey, R W | |
| 245 | 0 | 0 |
_aComparative study of cytosine arabinoside therapy alone and combined with thioguanine, mercaptopurine, or daunorubicin in acute myelocytic leukemia. _h[electronic resource] |
| 260 |
_bCancer _cNov 1975 |
||
| 300 |
_a1560-6 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aCytarabine _xtherapeutic use |
| 650 | 0 | 4 |
_aDaunorubicin _xtherapeutic use |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLeukemia, Myeloid, Acute _xcomplications |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMercaptopurine _xtherapeutic use |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aRemission, Spontaneous |
| 650 | 0 | 4 |
_aThioguanine _xtherapeutic use |
| 650 | 0 | 4 | _aTime Factors |
| 700 | 1 | _aRibas-Mundo, M | |
| 700 | 1 | _aEllison, R R | |
| 700 | 1 | _aGlidewell, O | |
| 700 | 1 | _aLee, S T | |
| 700 | 1 | _aCuttner, J | |
| 700 | 1 | _aLevy, R N | |
| 700 | 1 | _aSilver, R | |
| 700 | 1 | _aBlom, J | |
| 700 | 1 | _aHaurani, F | |
| 700 | 1 | _aSpurr, C L | |
| 700 | 1 | _aHarley, J B | |
| 700 | 1 | _aKyle, R | |
| 700 | 1 | _aMoon, J H | |
| 700 | 1 | _aEagan, R T | |
| 700 | 1 | _aHolland, J H | |
| 773 | 0 |
_tCancer _gvol. 36 _gno. 5 _gp. 1560-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/1097-0142(197511)36:5<1560::aid-cncr2820360504>3.0.co;2-5 _zAvailable from publisher's website |
| 999 |
_c1066797 _d1066797 |
||